Endocrinology
News
Cushing’s and COVID-19: Nontraditional symptoms keys to assessment, treatments
Features of Cushing’s syndrome may confound diagnosis and treatment of COVID-19, and also could make patients more susceptible to the pandemic.
Clinical
Canagliflozin protects diabetic kidneys
Do sodium-glucose cotransporter 2 (SGLT2) medications protect at-risk kidneys in type 2 diabetics?
News
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
The trial that turned an SGLT2 inhibitor into a heart failure drug also has clues to mechanisms behind the observed benefits. Contrary to early...
News
Cortisol levels on COVID-19 admission may be a marker of severity
Those with COVID-19 do appear to mount a stress response to the infection, and cortisol levels on admission to hospital can help determine the...
News
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that...
News
DAPA-HF: Dapagliflozin slows T2D onset in heart failure patients
News
For COVID-19 plus diabetes, glycemic control tops treatment list
Tight glucose control led to better results in patients with diabetes and COVID-19.
News
Half of type 1 diabetes patients with COVID-19 manage at home
Despite high rates of hyperglycemia and DKA, only about half of patients with type 1 diabetes and COVID-19 required hospitalization, according to...
News
‘The story unfolding is worrisome’ for diabetes and COVID-19
Diabetes Care has published a host of new articles on diabetes and COVID-19 infection, as NIDDK researchers also acknowledge risks to other organ...
Clinical
Sarcopenic obesity: The wasting within
Sarcopenic obesity is a form of deconditioning that occurs naturally with age.